Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn's disease
Turk J Gastroenterol
.
2016 Nov;27(6):568-569.
doi: 10.5152/tjg.2016.160008.
Authors
Ryan D Heath
1
,
Veysel Tahan
Affiliation
1
Division of Gastroenterology and Hepatology, University of Missouri- Columbia 1 Hospital Drive, Columbia, MO, USA. veyseltahan@yahoo.com.
PMID:
27852555
DOI:
10.5152/tjg.2016.160008
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal
Crohn Disease*
Gastrointestinal Agents*
Humans
Infliximab
Intestinal Fistula
Stem Cells
Treatment Outcome
Substances
Antibodies, Monoclonal
Gastrointestinal Agents
Infliximab